scispace - formally typeset
K

Koji Yamanaka

Researcher at Nagoya University

Publications -  111
Citations -  18199

Koji Yamanaka is an academic researcher from Nagoya University. The author has contributed to research in topics: Amyotrophic lateral sclerosis & SOD1. The author has an hindex of 42, co-authored 93 publications receiving 15572 citations. Previous affiliations of Koji Yamanaka include RIKEN Brain Science Institute & University of California, San Diego.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Neuroinflammation in Alzheimer's disease

Michael T. Heneka, +41 more
- 01 Apr 2015 - 
TL;DR: Genome-wide analysis suggests that several genes that increase the risk for sporadic Alzheimer's disease encode factors that regulate glial clearance of misfolded proteins and the inflammatory reaction.
Journal ArticleDOI

Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia

TL;DR: Onset and progression of amyotrophic lateral sclerosis represent distinct disease phases defined by mutant action within different cell types to generate non–cell-autonomous killing of motor neurons; these findings validate therapies, including cell replacement, targeted to the non-neuronal cells.
Journal ArticleDOI

Identification of the von Hippel–Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex

TL;DR: The results suggest that pVHL might be the substrate recognition subunit of the VBC-CUL-2 E3 ligase, the first example of a human tumor-suppressor protein being directly involved in the ubiquitin conjugation system which leads to the targeted degradation of substrate proteins.